ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 240529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 240529; 2) Community: the network communities that were significantly associated with the response to NSC 240529; 3) Molecule: the relationships between components within communities and NSC 240529; 4) MDR: the compounds that were significantly associated with the NSC 240529.

NSC Compound Enrichment Correlation
NSC 735406 Null 0.000532830026959993 0.230715
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.000532830026959993 0.48002013
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.000573863872925591 0.41100322
NSC 683557 Camptothecin Derivative 0.000573863872925591 0.72390879
NSC 746248 Null 0.000573863872925591 0.26835525
NSC 102627 Yoshi 864 0.000573863872925603 0.73831398
NSC 50273 Pyridine, 3-[[4-[bis(2-chloroethyl)amino]-2-methylbenzylidene]amino]- 0.000602374785885774 0.50036622
NSC 625603 Null 0.000610795106687072 0.3446248
NSC 697726 RH1 0.000610795106687072 0.71572944
NSC 702323 Null 0.000610795106687072 0.39769292
Total:99  Current:3    [First] [Prev] [Next] [Last]